Equity Overview
Price & Market Data
Price: $7.75
Daily Change: +$0.02 / 0.26%
Range: $7.69 - $7.75
Market Cap: $1,809,090,304
Volume: 4,133
Performance Metrics
1 Week: 3.78%
1 Month: -0.26%
3 Months: -16.05%
6 Months: -26.31%
1 Year: 7.55%
YTD: -14.84%
Company Details
Employees: 1611
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Denmark
Details
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.